1.61
2.55%
0.04
Handel nachbörslich:
1.61
Finanzdaten der Pmv Pharmaceuticals Inc-Aktie (PMVP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
6.76%
2.952
|
3.166 | 2.984 | 2.696 | 2.325 |
Operating Expenses
|
3.60%
18.22
|
18.90 | 19.63 | 20.12 | 21.48 |
Benefits Costs and Expenses |
3.70%
18.22
|
18.92 | 19.62 | 20.13 | 21.45 |
Costs And Expenses |
3.70%
18.22
|
18.92 | 19.62 | 20.13 | 21.45 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
3.60%
-18.22
|
-18.90 | -19.63 | -20.12 | -21.48 |
Net Interest Income/Expense |
6.76%
2.952
|
3.166 | 2.984 | 2.696 | 2.325 |
Interest Income/Expense After Provision For Losses |
6.76%
2.952
|
3.166 | 2.984 | 2.696 | 2.325 |
Income/Loss From Continuing Operations Before Tax |
3.09%
-15.27
|
-15.76 | -16.64 | -17.43 | -19.13 |
Income/Loss From Continuing Operations After Tax |
3.08%
-15.27
|
-15.76 | -16.64 | -17.44 | -19.13 |
Net Income/Loss
|
3.08%
-15.27
|
-15.76 | -16.64 | -17.44 | -19.13 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4,474%
51.45
|
1.1247 | 49.05 | 45.81 | 45.77 |
Diluted Average Shares |
4,474%
51.45
|
1.1247 | 49.05 | 45.81 | 45.77 |
Basic Earnings Per Share |
3.23%
-0.30
|
-0.31 | -0.34 | -0.38 | -0.42 |
Diluted Earnings Per Share |
3.23%
-0.30
|
-0.31 | -0.34 | -0.38 | -0.42 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):